Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Resources › Webinars › Precision Oncology Roundtable: Ask the Experts about NGS-based Tumor Profiling
October 12, 2017
Sponsored by
PierianDx

Precision Oncology Roundtable: Ask the Experts about NGS-based Tumor Profiling

Genome Webinar

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This webinar discussed the adoption of a commercial gene panel for tumor profiling at several leading US cancer centers.

Our expert panel — Gregory Tsongalis from Dartmouth-Hitchcock, Anthony Magliocco from Moffitt Cancer Center, Ravindra Kolhe from Augusta University, and Rakesh Nagarajan from PierianDx — specifically discuss their experiences with Illumina’s TruSight Tumor 170 targeted cancer assay.

Sponsored by
Oct
27
Featured Webinar

The Promise of Liquid Biopsy for Cancer Diagnostics and Therapeutic Monitoring: Are We There Yet?

Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.

What's Popular?

In Cancer

  1. Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD

  2. Biovica Files FDA 510(k) Submission for Breast Cancer Treatment Response Assay

  3. Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

  4. Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.